Substance-related disordersSubstance abuse treatmentMotivational interviewingMotivational enhancement therapyCognitive behavioral therapyTwelve-step facilitationContingency managementEvidence-based treatmentThere have been steady advances in psychotherapy for substance-related disorders. Several of these treatments are ...
A recent study found that in sexual minorities, internalized homophobia, lack of social support, andsubstance abuseproblems predicted problems with pornography.Depressionandanxietyare frequently reported symptoms in persons who struggle with pornography, and itappearsthat many of these persons use pornogra...
Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for substance use disorders and related conditions. We’re striving to help people with addiction overcome treatment obstacles and move forward on the path to a healthier lif
For decades, ibogaine the main psychoactive alkaloid found in Tabernanthe iboga has been investigated as a possible treatment for substance use disorders (SUDs) due to its purported ability to interrupt the addictive properties of multiple drugs of abuse. Of the numerous pharmacological actions of ...
Awakn Life Sciences is a clinical stage biotechnologies company developing therapeutics for substance use and mental health disorders, with a near-term focus on alcohol use disorder.
However, this information centered predominantly on improved formulary management for opioids, detection and engagement with overprescribers and doctor shoppers, and improved access to treatment for substance use disorders, and less so on innovations aimed at optimizing coverage and access to non...
J Subst Abuse Treat. 2011;41(3):243-251. doi:10.1016/j.jsat.2011.04.006PubMedGoogle ScholarCrossref 69. Humphreys K, Frank RG. The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction. 2014;109(12):1957-1958. doi:...
Because of their potential for abuse and effects on addiction-related pathways in the brain (through dopamine), stimulants are also not suitable for people with substance abuse disorders. Stimulants, particularly amphetamines, can also induce mania or psychosis in some people who have not previousl...
Summary As the number of older adults aged ≥50 years rise and requests of treatment for substance use disorders increase, there is an emerging need to identify efficient interventions. Research on pharmacological management of substance abuse among older individuals is scant. Existing evidence is ...
The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying...